The Feedback Loop – Part 2 of a conversation with Cal Henderson, Co-Founder of Slack
An incredibly reactive and evolutionary software, Slack is constantly learning from its users and challenging its creators’ view of how it is used. Changes between different types of customer layered ...
3 Mars 202223min
The Death of Email? – Part 1 of a conversation with Cal Henderson, Co-Founder of Slack
Initially developed as a direct digitisation of the inter-departmental memo, email has been long embedded into our work lives. The emergence of a new generation of workplace communication tools aim to...
3 Mars 202228min
The Digital Construction Site: Trackunit’s Soeren Brogaard on transparency and connection
Trackunit is quietly revolutionising and illuminating the construction industry. By bringing data and analysis to a world where high levels of uncertainty and unpredictability lead to low margins, ope...
3 Mars 202220min
Never a better time than now: team.blue’s Jonas Dhaenens and his Founder’s journey
Having founded Benelux-based web services group, team.blue (then Combell), at the age of 16, Jonas Dhaenens has stayed with his business through growth, outside investment, international expansion and...
3 Mars 202213min
The Future of SaaS - Part 2: Input is Error
Part 2 of our miniseries: 'The Future of SaaS' The benefits of the SaaS model is increasingly well recognised and is well placed to be the next move for the majority of B2B software. In this episode...
3 Mars 202215min
The Future of SaaS - Part 1: Visma’s Øystein Moan on the advantages of SaaS, the challenges to get there and how much road there is left
Part 1 of our miniseries: 'The Future of SaaS' The benefits of the SaaS model is increasingly well recognised, but the pain and challenges to successfully achieve a SaaS transition is now being felt ...
10 Nov 202124min
Data Science in Drug Development: Evaluate’s Jon Moser on what biopharma learnt about data science in 2020
The COVID-19 pandemic has been incredibly disruptive for people all across the world, but has really thrown the spotlight on pharma companies. We’ve seen drugs designed and developed in record times. ...
10 Nov 202118min
The Art of Cross-sell: Peter Sherlock on how the Citation Group built a cross-sell engine
As a fast-growing business, with many business units newly added through M&A, Citation had huge cross-selling opportunities. But taking cross-selling from opportunistic to strategic took a whole host ...
10 Nov 202124min
